Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.6419
+0.0522 ( -20.51% ) 150.7M
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.